ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Congress Passes NIH Reauthorization.

December 15, 2006

Tacoma Hospital Finds Cancer DRGs Are Profitable

February 17, 1984

House May Add $80 Million To NCI Budget For FY 1984

September 16, 1983

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

Eight Practicing Physicians On Board are Enough, Need Some Scientists Now, DeVita Says

December 9, 1983

Preoperative Drug Combo Benefits HER-2 Breast Cancer

April 29, 2005